Download PDF
J Knee Surg 2019; 32(01): 097-104
DOI: 10.1055/s-0038-1636834
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Comparison of Techniques for Preimplantation Treatment of Osteochondral Allograft Bone

Charles A. Baumann
1   University of Missouri School of Medicine, Columbia, Missouri
2   Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
,
John R. Baumann
2   Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
,
Chantelle C. Bozynski
2   Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
3   Department of Orthopaedic Surgery, University of Missouri, Columbia, Missouri
,
Aaron M. Stoker
2   Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
3   Department of Orthopaedic Surgery, University of Missouri, Columbia, Missouri
,
James P. Stannard
2   Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
3   Department of Orthopaedic Surgery, University of Missouri, Columbia, Missouri
,
James L. Cook
2   Thompson Laboratory for Regenerative Orthopaedics, University of Missouri, Columbia, Missouri
3   Department of Orthopaedic Surgery, University of Missouri, Columbia, Missouri
› Author Affiliations Funding None.
Further Information

Publication History

08 January 2018

28 January 2018

Publication Date:
07 March 2018 (online)

    Permissions and Reprints

Abstract

Articular defects are a major problem with few effective treatment options. Osteochondral allograft (OCA) transplantation can be an effective treatment; however, lack of OCA bone integration can cause failure. This controlled laboratory study was designed to compare clinically applicable methods for marrow element removal and enhanced delivery of bone marrow aspirate concentrate (BMC) to OCA bone. We hypothesized that compressed carbon dioxide (CO2) treatment of OCA bone would result in significantly better marrow element removal, significantly more retention and distribution of viable osteoprogenitor cells, and significantly higher osteoinductive protein elution from OCAs compared with other preimplantation treatments. Fresh humeral heads (n = 24) were harvested and stored for 14 days, then randomly assigned to treatment based on marrow element removal and bone treatment: (standard of care [SOC]) (n = 4) – SOC high-pulse saline lavage, no BMC; (BMC) (n = 5) – saline lavage then canine BMC; (Drill + BMC) (n = 5) – 1.1 mm drill-hole immediately subchondral then saline lavage then BMC injection through drill hole; (Carb + BMC) (n = 5) – saline lavage then CO2 then BMC; or (Saline-Carb + BMC) (n = 5) – saline lavage and CO2 together then BMC. Treated OCAs were cultured for 14 days. On day 3, media were collected, centrifuged to isolate cells, and replaced. Cells were cultured for 11 days for colony forming unit (CFU) determination. OCA media were collected on days 7 and 14 of culture for analysis. On day 14, each graft was assessed for viable cell retention and distribution, and bone marrow element removal. BMC had significantly higher (p = 0.001) viable cell distribution compared with the SOC, Drill + BMC, Carb + BMC, and Saline-Carb + BMC groups. BMC and Drill + BMC had significantly higher (p < 0.05) CFUs than SOC, Carb + BMC, and Saline-Carb + BMC. Drill + BMC and Carb + BMC had the highest media concentrations of the osteoinductive biomarkers. The Carb + BMC and Saline-Carb + BMC groups were associated with significantly superior marrow element removal (p < 0.02) compared with the SOC, Drill + BMC, and BMC groups. Saline irrigation plus saturation with autogenous BMC appears to be the most advantageous preimplantation treatment for OCA transplantation.

Keywords

osteochondral allograft - bone marrow aspirate concentrate - orthobiologics - bone marrow removal - transplantation

Note

This study was approved by our university's Animal Care and Use Committee.


 

  • References

  • 1 Heir S, Nerhus TK, Røtterud JH. , et al. Focal cartilage defects in the knee impair quality of life as much as severe osteoarthritis: a comparison of knee injury and osteoarthritis outcome score in 4 patient categories scheduled for knee surgery. Am J Sports Med 2010; 38 (02) 231-237
    CrossrefPubMedGoogle Scholar
  • 2 Versier G, Dubrana F. ; French Arthroscopy Society. Treatment of knee cartilage defect in 2010. Orthop Traumatol Surg Res 2011; 97 (8, Suppl): S140-S153
    CrossrefPubMedGoogle Scholar
  • 3 Buckwalter JA. Articular cartilage: injuries and potential for healing. J Orthop Sports Phys Ther 1998; 28 (04) 192-202
    CrossrefPubMedGoogle Scholar
  • 4 Kuroki K, Stoker AM, Stannard JP. , et al. Biologic joint repair strategies: the Mizzou BioJoint story. Toxicol Pathol 2017; 45 (07) 931-938
    CrossrefPubMedGoogle Scholar
  • 5 Nuelle CW, Nuelle JA, Cook JL, Stannard JP. Patient factors, donor age, and graft storage duration affect osteochondral allograft outcomes in knees with or without comorbidities. J Knee Surg 2017; 30 (02) 179-184
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Nielsen ES, McCauley JC, Pulido PA, Bugbee WD. Return to sport and recreational activity after osteochondral allograft transplantation in the knee. Am J Sports Med 2017; 45 (07) 1608-1614
    CrossrefPubMedGoogle Scholar
  • 7 Gracitelli GC, Tirico LE, McCauley JC, Pulido PA, Bugbee WD. Fresh osteochondral allograft transplantation for fractures of the knee. Cartilage 2017; 8 (02) 155-161
    CrossrefPubMedGoogle Scholar
  • 8 Farr J, Gracitelli GC, Shah N, Chang EY, Gomoll AH. High failure rate of a decellularized osteochondral allograft for the treatment of cartilage lesions. Am J Sports Med 2016; 44 (08) 2015-2022
    CrossrefPubMedGoogle Scholar
  • 9 Assenmacher AT, Pareek A, Reardon PJ, Macalena JA, Stuart MJ, Krych AJ. Long-term outcomes after osteochondral allograft: a systematic review at long-term follow-up of 12.3 years. Arthroscopy 2016; 32 (10) 2160-2168
    CrossrefPubMedGoogle Scholar
  • 10 Sherman SL, Garrity J, Bauer K, Cook J, Stannard J, Bugbee W. Fresh osteochondral allograft transplantation for the knee: current concepts. J Am Acad Orthop Surg 2014; 22 (02) 121-133
    PubMedGoogle Scholar
  • 11 Gross AE, Kim W, Las Heras F, Backstein D, Safir O, Pritzker KP. Fresh osteochondral allografts for posttraumatic knee defects: long-term follow-up. Clin Orthop Relat Res 2008; 466 (08) 1863-1870
    CrossrefPubMedGoogle Scholar
  • 12 Gross AE, Shasha N, Aubin P. Long-term follow-up of the use of fresh osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res 2005; (435) 79-87
    PubMedGoogle Scholar
  • 13 Murphy RT, Pennock AT, Bugbee WD. Osteochondral allograft transplantation of the knee in the pediatric and adolescent population. Am J Sports Med 2014; 42 (03) 635-640
    CrossrefPubMedGoogle Scholar
  • 14 Pritzker KP, Gross AE, Langer F, Luk SC, Houpt JB. Articular cartilage transplantation. Hum Pathol 1977; 8 (06) 635-651
    CrossrefPubMedGoogle Scholar
  • 15 Stoker AM, Baumann CA, Stannard JP, Cook JL. Bone marrow aspirate concentrate versus platelet rich plasma to enhance osseous integration potential for osteochondral allografts. J Knee Surg 2017; DOI: 10.1055/s-0037-1603800.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Oladeji LO, Stannard JP, Cook CR. , et al. Effects of autogenous bone marrow aspirate concentrate on radiographic integration of femoral condylar osteochondral allografts. Am J Sports Med 2017; 45 (12) 2797-2803
    CrossrefPubMedGoogle Scholar
  • 17 Smyth NA, Murawski CD, Haleem AM, Hannon CP, Savage-Elliott I, Kennedy JG. Establishing proof of concept: platelet-rich plasma and bone marrow aspirate concentrate may improve cartilage repair following surgical treatment for osteochondral lesions of the talus. World J Orthop 2012; 3 (07) 101-108
    CrossrefPubMedGoogle Scholar
  • 18 Dawson JI, Smith JO, Aarvold A. , et al. Enhancing the osteogenic efficacy of human bone marrow aspirate: concentrating osteoprogenitors using wave-assisted filtration. Cytotherapy 2013; 15 (02) 242-252
    CrossrefPubMedGoogle Scholar
  • 19 Fortier LA, Potter HG, Rickey EJ. , et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am 2010; 92 (10) 1927-1937
    CrossrefPubMedGoogle Scholar
  • 20 Shapiro E, Grande D, Drakos M. Biologics in Achilles tendon healing and repair: a review. Curr Rev Musculoskelet Med 2015; 8 (01) 9-17
    CrossrefPubMedGoogle Scholar
  • 21 Gianakos A, Ni A, Zambrana L, Kennedy JG, Lane JM. Bone marrow aspirate concentrate in animal long bone healing: an analysis of basic science evidence. J Orthop Trauma 2016; 30 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 22 Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin Orthop Relat Res 2011; 469 (10) 2706-2715
    CrossrefPubMedGoogle Scholar
  • 23 Ardjomandi N, Duttenhoefer F, Xavier S, Oshima T, Kuenz A, Sauerbier S. In vivo comparison of hard tissue regeneration with ovine mesenchymal stem cells processed with either the FICOLL method or the BMAC method. J Craniomaxillofac Surg 2015; 43 (07) 1177-1183
    CrossrefPubMedGoogle Scholar
  • 24 Sauerbier S, Stricker A, Kuschnierz J. , et al. In vivo comparison of hard tissue regeneration with human mesenchymal stem cells processed with either the FICOLL method or the BMAC method. Tissue Eng Part C Methods 2010; 16 (02) 215-223
    CrossrefPubMedGoogle Scholar
  • 25 Bourzac C, Smith LC, Vincent P, Beauchamp G, Lavoie JP, Laverty S. Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols. Equine Vet J 2010; 42 (06) 519-527
    CrossrefPubMedGoogle Scholar
  • 26 Jäger M, Herten M, Fochtmann U. , et al. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2011; 29 (02) 173-180
    CrossrefPubMedGoogle Scholar
  • 27 Bastian JD, Egli RJ, Ganz R, Hofstetter W, Leunig M. Chondrocytes within osteochondral grafts are more resistant than osteoblasts to tissue culture at 37°C. J Invest Surg 2011; 24 (01) 28-34
    CrossrefPubMedGoogle Scholar
  • 28 Zhong W, Sumita Y, Ohba S. , et al. In vivo comparison of the bone regeneration capability of human bone marrow concentrates vs. platelet-rich plasma. PLoS One 2012; 7 (07) e40833
    CrossrefPubMedGoogle Scholar
  • 29 Gessmann J, Köller M, Godry H, Schildhauer TA, Seybold D. Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia) 2012; 4 (01) e14
    PubMedGoogle Scholar
  • 30 Sununliganon L, Peng L, Singhatanadgit W, Cheung LK. Osteogenic efficacy of bone marrow concentrate in rabbit maxillary sinus grafting. J Craniomaxillofac Surg 2014; 42 (08) 1753-1765
    CrossrefPubMedGoogle Scholar
  • 31 Chahla J, Dean CS, Moatshe G, Pascual-Garrido C, Serra Cruz R, LaPrade RF. Concentrated bone marrow aspirate for the treatment of chondral injuries and osteoarthritis of the knee: a systematic review of outcomes. Orthop J Sports Med 2016; 4 (01) 2325967115625481
    CrossrefPubMedGoogle Scholar
  • 32 Holton J, Imam MA, Snow M. Bone marrow aspirate in the treatment of chondral injuries. Front Surg 2016; 3: 33
    PubMedGoogle Scholar
  • 33 Krych AJ, Nawabi DH, Farshad-Amacker NA. , et al. Bone marrow concentrate improves early cartilage phase maturation of a scaffold plug in the knee: a comparative magnetic resonance imaging analysis to platelet-rich plasma and control. Am J Sports Med 2016; 44 (01) 91-98
    CrossrefPubMedGoogle Scholar
  • 34 Enea D, Cecconi S, Calcagno S, Busilacchi A, Manzotti S, Gigante A. One-step cartilage repair in the knee: collagen-covered microfracture and autologous bone marrow concentrate. A pilot study. Knee 2015; 22 (01) 30-35
    CrossrefPubMedGoogle Scholar
  • 35 Skowroński J, Skowroński R, Rutka M. Large cartilage lesions of the knee treated with bone marrow concentrate and collagen membrane--results. Ortop Traumatol Rehabil 2013; 15 (01) 69-76
    PubMedGoogle Scholar
  • 36 Kasemkijwattana C, Hongeng S, Kesprayura S, Rungsinaporn V, Chaipinyo K, Chansiri K. Autologous bone marrow mesenchymal stem cells implantation for cartilage defects: two cases report. J Med Assoc Thai 2011; 94 (03) 395-400
    PubMedGoogle Scholar
  • 37 Gobbi A, Karnatzikos G, Scotti C, Mahajan V, Mazzucco L, Grigolo B. One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2-year follow-up. Cartilage 2011; 2 (03) 286-299
    CrossrefPubMedGoogle Scholar
  • 38 Sun Y, Jiang W, Cory E. , et al. Pulsed lavage cleansing of osteochondral grafts depends on lavage duration, flow intensity, and graft storage condition. PLoS One 2017; 12 (05) e0176934
    CrossrefPubMedGoogle Scholar
  • 39 VandeVord PJ, Nasser S, Wooley PH. Immunological responses to bone soluble proteins in recipients of bone allografts. J Orthop Res 2005; 23 (05) 1059-1064
    CrossrefPubMedGoogle Scholar
  • 40 Lewandrowski KU, Rebmann V, Pässler M. , et al. Immune response to perforated and partially demineralized bone allografts. J Orthop Sci 2001; 6 (06) 545-555
    CrossrefPubMedGoogle Scholar
  • 41 Strong DM, Friedlaender GE, Tomford WW. , et al. Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop Relat Res 1996; (326) 107-114
    PubMedGoogle Scholar
  • 42 Stevenson S. The immune response to osteochondral allografts in dogs. J Bone Joint Surg Am 1987; 69 (04) 573-582
    CrossrefPubMedGoogle Scholar
  • 43 Haimi S, Wahlman M, Mannila M, Virtanen V, Hirn M. Pulse-lavage washing is an effective method for defatting of morselized allograft bone in the operating theater. Acta Orthop 2008; 79 (01) 94-97
    CrossrefPubMedGoogle Scholar
  • 44 Meyer MA, McCarthy MA, Gitelis ME. , et al. Effectiveness of lavage techniques in removing immunogenic elements from osteochondral allografts. Cartilage 2017; 8 (04) 369-373
    CrossrefPubMedGoogle Scholar
  • 45 Cook JL, Stannard JP, Stoker AM. , et al. Importance of donor chondrocyte viability for osteochondral allografts. Am J Sports Med 2016; 44 (05) 1260-1268
    CrossrefPubMedGoogle Scholar
  • 46 Pallante AL, Chen AC, Ball ST. , et al. The in vivo performance of osteochondral allografts in the goat is diminished with extended storage and decreased cartilage cellularity. Am J Sports Med 2012; 40 (08) 1814-1823
    CrossrefPubMedGoogle Scholar
  • 47 Stoker AM, Stannard JP, Kuroki K, Bozynski CC, Pfeiffer FM, Cook JL. Validation of the Missouri Osteochondral Allograft Preservation System for the maintenance of osteochondral allograft quality during prolonged storage. Am J Sports Med 2018; 46 (01) 58-65
    CrossrefPubMedGoogle Scholar
  • 48 Cook JL, Stoker AM, Stannard JP. , et al. A novel system improves preservation of osteochondral allografts. Clin Orthop Relat Res 2014; 472 (11) 3404-3414
    CrossrefPubMedGoogle Scholar
  • 49 Stoker A, Garrity JT, Hung CT, Stannard JP, Cook J. Improved preservation of fresh osteochondral allografts for clinical use. J Knee Surg 2012; 25 (02) 117-125
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Stoker AM, Stannard JP, Cook JL. Chondrocyte viability at time of transplantation for osteochondral allografts preserved by the Missouri Osteochondral Preservation System versus standard tissue bank protocol. J Knee Surg 2017; DOI: 10.1055/s-0037-1608947.
    Article in Thieme ConnectPubMedGoogle Scholar